(Q36731951)

15 August 2017

1 reference

title

Cytokine regulation of eosinophil function (English)

1 reference

15 August 2017

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

10 November 2022

author name string

P. F. Weller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1728988

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728988

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:009012299290041L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

https://api.elsevier.com/content/article/PII:009012299290041L?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Clinical Immunology and Immunopathology

10 November 2022

published in

1 reference

15 August 2017

volume

62

1 reference

15 August 2017

issue

1 Pt 2

1 reference

15 August 2017

page(s)

S55-9

1 reference

Eosinophilia in transgenic mice expressing interleukin 5.

15 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

10 November 2022

The interleukins

5

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Interleukin 5 activity in sera from patients with eosinophilia.

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Interferon-alpha for the hypereosinophilic syndrome

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Alfa-interferon in a case of hypereosinophilic syndrome

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

The eosinophilic leukocyte: structure and function

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Heterogeneity of Leukotriene C4Production by Eosinophils from Asthmatic and from Normal Subjects

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Altered density, metabolism and surface receptors of eosinophils in eosinophilia

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Comparison of human eosinophils from normals and patients with eosinophilia

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Recombinant human interleukin 5 is a selective activator of human eosinophil function

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Recombinant human interleukin 5 is a selective eosinophil chemoattractant

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Eosinophils cocultured with endothelial cells have increased survival and functional properties.

10 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro

10 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Mature human eosinophils have the capacity to express HLA-DR

10 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120

10 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset

10 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF)

10 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration

10 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human eosinophils express functional interleukin 2 receptors

10 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

Human eosinophils express transforming growth factor alpha

10 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90041-L

10 November 2022

Identifiers

1 reference

15 August 2017

1 reference